![Roni Mamluk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roni Mamluk
Direktör/Styrelseledamot på
REDHILL BIOPHARMA LTD.
Förmögenhet: 1 M $ per 2026-10-31
Profil
Roni Mamluk currently works at RedHill Biopharma Ltd., as Independent Director from 2024 and Israel Biotech Fund, as Venture Advisor.
Dr. Mamluk also formerly worked at Old Ayala, Inc., as President, Chief Executive Officer & Director, Chiasma, Inc., as Independent Director from 2017 to 2021, Chiasma (Israel) Ltd., as Director from 2017 to 2021, Amryt Pharma Holdings Ltd., as Non-Executive Director, Amryt Pharma Ltd., as Non-Executive Director from 2021 to 2023, and Adnexus, as Head-Non Clinical Research & Development.
Dr. Mamluk received her undergraduate degree and doctorate degree from The Hebrew University of Jerusalem and graduate degree in 2004 from Harvard Medical School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
REDHILL BIOPHARMA LTD. 0,05 % | 2026-04-27 | 28 120 000 ( 0,05 % ) | 1 M $ | 2026-10-31 |
Aktiva positioner av Roni Mamluk
| Företag | Position | Start |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Direktör/Styrelseledamot | 2024-09-01 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Konsult / Rådgivare | - |
Tidigare kända positioner av Roni Mamluk
| Företag | Position | Slut |
|---|---|---|
| ADVAXIS, INC. | Verkställande Direktör | 2023-01-19 |
| AMRYT PHARMA PLC | Direktör/Styrelseledamot | 2023-01-01 |
Chiasma (Israel) Ltd. | Direktör/Styrelseledamot | 2021-08-01 |
| CHIASMA, INC. | Verkställande Direktör | 2015-06-17 |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Företagsledare/Principal | - |
Roni Mamluks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
63
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chiasma (Israel) Ltd. | |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RedHill Biopharma Ltd.
 RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company which develops cancer therapies | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
